title: Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection in a nurse with atopic dermatitis.
authors.affiliation: Department of Dermatology, University of Regensburg, Franz-Josef-Strauss-Allee 11, D-91053 Regensburg, Germany. alexander.roesch@klinik.uni-regensburg.de
authors.forename: Alexander
authors.initials: A
authors.lastname: Roesch
authors.forename: Hans-Joerg
authors.initials: HJ
authors.lastname: Linde
authors.forename: Michael
authors.initials: M
authors.lastname: Landthaler
authors.forename: Thomas
authors.initials: T
authors.lastname: Vogt
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D016712:Mupirocin / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013207:Staphylococcal Skin Infections / Q000188:drug therapy* / Q000628:therapy; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification; D016896:Treatment Outcome; D014260:Triclosan / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000891:Anti-Infective Agents, Local; D000904:Antibiotics, Antitubercular; D014260:Triclosan; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D016712:Mupirocin; D012293:Rifampin